Photo: © Lloyd Johnson
The idea was to start a new company to develop inhaled insulin for diabetes. This company was built around David's article (Idea 3) and with his former postdoc advisor Robert Langer and venture capitalist Terry McGuire of Polaris Ventures. It started and sold to Alkermes in less than two years. For more information, click here.